Long-acting injectable naltrexone for the management of patients with opioid dependence

Substance Abuse : Research and Treatment
Kimberly L Kjome, F Gerard Moeller

Abstract

Opioid dependence is a condition with serious clinical ramifications. Treatment has focused on detoxification, agonist therapy with methadone or buprenorphine, or remission maintenance with the opioid antagonist, naltrexone. Treatment with oral naltrexone has been limited by poor treatment adherence and relapse. Studies with long-acting formulations have shown increased treatment adherence. Extended-release injectable naltrexone has been used for the treatment of alcohol dependence, and has recently received an indication for treatment of opioid dependence from the US Food and Drug Administration. Dosing occurs once monthly and existing data with long-acting naltrexone supports efficacy of treatment for opioid dependence; however published data is sparse. Treatment with long-acting naltrexone should be monitored for hepatotoxicity, and patients should be made aware of increased risk of overdose with administration of opioids during and immediately after discontinuation of long-acting naltrexone.

References

Mar 1, 1979·Comprehensive Psychiatry·R B ResnickA M Washton
Oct 1, 1977·The International Journal of the Addictions·Herbert D Kleber
Jan 1, 1975·The American Journal of Drug and Alcohol Abuse·K Verebey, S J Mulé
Jan 1, 1975·The American Journal of Drug and Alcohol Abuse·C P O'BrienG E Woody
Sep 1, 1990·Acta Psychiatrica Scandinavica·L GrönbladhL M Gunne
Jan 1, 1989·Journal of Substance Abuse Treatment·D H FramR Holden
Jan 1, 1988·Reviews in Clinical & Basic Pharmacology·B C Yoburn
Jun 19, 1969·The New England Journal of Medicine·V P DoleE Caine
Jan 1, 1981·The American Journal of Drug and Alcohol Abuse·R A GreensteinA Vittor
Feb 1, 1994·Drug and Alcohol Dependence·V NavaratnamS M Mansor
Jun 15, 1994·Biological Psychiatry·E N ShufmanY Ginath
May 1, 1994·Clinical Pharmacology and Therapeutics·S L WalshGeorge E Bigelow
Apr 27, 1999·Drug and Alcohol Dependence·Kenzie L PrestonC R Schuster
Feb 2, 2002·Psychopharmacology·Sandra D ComerMarian W Fischman
Dec 24, 2002·Journal of Substance Abuse Treatment·Jami L RothenbergE V Nunes
Feb 28, 2006·Alcoholism, Clinical and Experimental Research·Joi L DunbarKenneth C Lasseter
Apr 6, 2006·The American Journal on Addictions·Maria A SullivanE V Nunes
Jul 15, 2006·Alcohol·Mao-Hsiung YenJau-Shyong Hong
Nov 18, 2006·Journal of Clinical Psychopharmacology·Helen M PettinatiCharles A Dackis
Nov 28, 2006·The American Journal of Drug and Alcohol Abuse·E V NunesHerbert D Kleber
Aug 8, 2007·Drug and Alcohol Dependence·Maria A SullivanE V Nunes
Oct 26, 2007·Journal of Studies on Alcohol and Drugs·Joi L DunbarColm B Farrell
Nov 27, 2007·Substance Abuse Treatment, Prevention, and Policy·Albert Stuart Reece
Jan 10, 2008·Journal of the National Cancer Institute·Marcia Bellon, Christophe Nicot
Feb 5, 2008·Alcoholism, Clinical and Experimental Research·Michael R LuceyCharles P O'Brien
Jun 24, 2008·Science & Practice Perspectives·Thomas Kosten, Tony P George
Jun 23, 2009·Expert Opinion on Pharmacotherapy·Angela L StottsThomas Kosten
Nov 21, 2009·European Psychiatry : the Journal of the Association of European Psychiatrists·J RoddaZ Walker

Citations

Nov 30, 2013·The Journal of Prosthetic Dentistry·Ralf BuergersVeronika Vielsmeier
Sep 28, 2015·Chemico-biological Interactions·Dijendra Nath Roy, Ritobrata Goswami
Mar 31, 2015·Journal of Substance Abuse Treatment·Elias Dakwar, Herbert D Kleber
Sep 15, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Andrew Wilson, Joshua Cohen
May 30, 2019·Health & Justice·Jessica Reichert, Lily Gleicher
Mar 22, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Roxanne SaucierNabarun Dasgupta

Related Concepts

Alcoholic Intoxication, Chronic
Buprenorphine
Methadone
Naltrexone
Narcotic Antagonists
Detoxification Procedure
Hepatotoxicity
Opioids
Agonists
Disease Management

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.